Acacia Pharma is a hospital pharmaceutical group focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer therapy.
Procedural Sedation/Induction
CINV is one of the most common and feared side effects of cancer chemotherapy
| Status | Exited |
| Website | https://acaciapharma.com/ |
| Category | Biotech |
| Modality | Small Molecule |
| Therapautics Area | Oncology |
| Headquaters | Cambridge, UK |
| Partner | Cosmo Pharmaceuticals |
| Investment Portfolio | Pre-Fund Investment |
| Co-Investors | F-Prime Capital Partners, Novo Holdings Lundbeckfond Ventures, Gilde Healthcare Partners |